204 related articles for article (PubMed ID: 30811699)
1. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
2. Modelling first-year cost-of-illness of melanoma attributable to sunbed use in Europe.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():46-56. PubMed ID: 30811692
[TBL] [Abstract][Full Text] [Related]
3. Cost-of-illness of melanoma in Europe - a systematic review of the published literature.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246
[TBL] [Abstract][Full Text] [Related]
4. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
5. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):709-722. PubMed ID: 34329626
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R; Leal J; Sullivan R; Luengo-Fernandez R
Lancet Haematol; 2016 Aug; 3(8):e362-70. PubMed ID: 27476787
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
10. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
11. Societal cost of skin cancer in Sweden in 2005.
Tinghög G; Carlsson P; Synnerstad I; Rosdahl I
Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884
[TBL] [Abstract][Full Text] [Related]
12. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.
Guy GP; Ekwueme DU
Pharmacoeconomics; 2011 Oct; 29(10):863-74. PubMed ID: 21846158
[TBL] [Abstract][Full Text] [Related]
13. Estimating the economic costs of skin cancer in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
[TBL] [Abstract][Full Text] [Related]
14. Modelling the healthcare costs of skin cancer in South Africa.
Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Luengo-Fernandez R; Burns R; Leal J
Lancet Haematol; 2016 Aug; 3(8):e371-8. PubMed ID: 27476788
[TBL] [Abstract][Full Text] [Related]
16. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
17. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Appl Health Econ Health Policy; 2023 Nov; 21(6):877-889. PubMed ID: 37552416
[TBL] [Abstract][Full Text] [Related]
18. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
19. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
Hanly P; Soerjomataram I; Sharp L
Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of cancer care for Syrian refugees: a population-based modelling study.
Abdul-Khalek RA; Guo P; Sharp F; Gheorghe A; Shamieh O; Kutluk T; Fouad F; Coutts A; Aggarwal A; Mukherji D; Abu-Sittah G; Chalkidou K; Sullivan R;
Lancet Oncol; 2020 May; 21(5):637-644. PubMed ID: 32359488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
